Analyst Ratings For NASDAQ:ENTA – Enanta Pharmaceuticals (NASDAQ:ENTA)
Today, Roth Capital initiated coverage on NASDAQ:ENTA – Enanta Pharmaceuticals (NASDAQ:ENTA) with a Buy with a price target of $133.00.
Some recent analyst ratings include
- 6/6/2018-Roth Capital initiated coverage with a Buy rating.
- 5/24/2018-Oppenheimer initiated coverage with a Buy rating.
- 4/4/2018-Royal Bank of Canada Reiterated Rating of Hold.
- 2/8/2018-JPMorgan Chase & Co. was Downgraded by analysts at JPMorgan Chase & Co. from a “Overweight ➝ Neutral” rating to a “” rating.
Recent Insider Trading Activity For NASDAQ:ENTA – Enanta Pharmaceuticals (NASDAQ:ENTA)
NASDAQ:ENTA – Enanta Pharmaceuticals (NASDAQ:ENTA) has insider ownership of 10.56% and institutional ownership of 76.15%.
- On 5/17/2018 Jay R Luly, Insider, sold 25,000 with an average share price of $105.83 per share and the total transaction amounting to $2,645,750.00.
- On 5/16/2018 Nathalie Adda, VP, sold 4,155 with an average share price of $105.25 per share and the total transaction amounting to $437,313.75.
- On 4/16/2018 Nathalie Adda, VP, sold 4,225 with an average share price of $85.58 per share and the total transaction amounting to $361,575.50.
- On 3/19/2018 Paul J Mellett, Treasurer, sold 9,000 with an average share price of $86.48 per share and the total transaction amounting to $778,320.00.
- On 1/4/2017 Yat Sun Or, Insider, sold 13,921 with an average share price of $35.09 per share and the total transaction amounting to $488,487.89.
- On 11/29/2016 Yat Sun Or, Insider, sold 13,921 with an average share price of $31.44 per share and the total transaction amounting to $437,676.24.
- On 5/11/2016 Nathaniel S Gardiner, VP, bought 500 with an average share price of $24.45 per share and the total transaction amounting to $12,225.00.
Recent Trading Activity for NASDAQ:ENTA – Enanta Pharmaceuticals (NASDAQ:ENTA)
Shares of NASDAQ:ENTA – Enanta Pharmaceuticals closed the previous trading session at with 28982 shares trading hands.